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SIGNIFICANCE OF BLOOD SUGAR AND SERUM ELECTROLYTE CHANGES IN
CIRRHOSIS FOLLOWING GLUCOSE, INSULIN, GLUCAGON, OR EPINEPHRINE§
It has been established that the administration of glucose, insulin, or
epinephrine to control and experimental subjects produces a decrease
in serum inorganic phosphorus and, less consistently, in serum potas-
sium1 'I12-16, 1821, 23-28, 34. 85,87-43,47'48.4., 57, 5. 64,66 Nin addition to the change in
blood sugar levels. Cirrhosis is known to affect the blood sugar responses to
alterations of carbohydrate metabolism by these agents,5'10 2 ." "'e but data
on associated electrolyte changes are few, limited to measurements of serum
inorganic phosphorus and of potassium, and often inconclusive. The studies
herein described indicate that changes in other electrolytes may also occur
following glucose, insulin, glucagon, or epinephrine administration and that
their direction and magnitude may serve as an index of alterations in carbo-
hydrate metabolism induced by these agents.
MATERIALS AND METHODS
Glucose (0.5 gram/kilogram) and crystalline insulin (0.1 unit/kilogram), alone or
in combination, and glucagon (16 gamma/kilogram) were rapidly administered by
vein to healthy young adults or patients hospitalized with cirrhosis. Epinephrine (0.01
milliliter/kilogram of a 1: 1000 solution) was injected in divided dosage subcutane-
ously at 0, 10, and 20 minutes to similar groups of subjects. Venous blood withdrawn
with minimum stasis prior to and at intervals following the above injections was
analyzed for concentrations of sugar in blood and for levels of inorganic phosphorus,
potassium, total carbon dioxide, chloride, and sodium in serum.11
The presence of cirrhosis was established in each instance by needle biopsy of the
liver in addition to the demonstration of the characteristic abnormalities of serum
proteins, decreased bromsulphalein excretion, elevated bilirubin levels, etc. The toler-
ance studies were conducted once convalescence from hepatic decompensation had been
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well established, i.e., alcoholic intake had been stopped, food intake resumed, and
ascites and edema largely or entirely delivered.
Rates of glucose disappearance in cirrhotics and in control subjects have been
estimated for the intervals between 0 and 30 and 0 and 60 minutes following glucose
and glucose-insulin administration, assuming that glucose was distributed in a volume
of extracellular fluid equivalent to 20 per cent of the body weight. Calculations were
made in accordance with the usual formula save that the correction for the higher
glucose concentration in extracellular fluid has been omitted:
B1.S. (mgm. per liter) X ECW (liters) + Injected glucose in
milligrams = Total Extracellular Glucose or mgm. GlucoseECW
Then:
mgm. GlucoseECWStart minus mgm. GlucoseECWFinish _. B Wgt (kgm)
Time(minutes)
Average Disappearance Rate (mgm./min./kgm.) during given interval
Similar calculations for glucagon, insulin, and epinephrine were not attempted because
the magnitude of the increment of glucose from hepatic glycogen in the case of the first
and from hepatic and/or tissue glycogen in the last two cannot be measured. In the
glucose and glucose-insulin calculations it was assumed that the increment in glucose
load came from exogenous sources only.
A. Changes in blood sugar and serum electrolytes follozwing intravenous glucose
The rapid intravenous injection of glucose, 0.5 gram/kilogram of body weight,
produced a rise in the blood sugar levels of adult patients with cirrhosis which was
greater and more prolonged than that seen in healthy young adults under similar
circumstances. Calculation of the average rate of glucose disappearance showed that in
keeping with the hyperglycemia the cirrhotic patients disposed of less glucose during
the 0 to 30- and 0 to 60-minute intervals (Table 1). This relatively greater hypergly-
cemia was accompanied by a more pronounced and more protracted decrease in serum
inorganic phosphorus (Fig. 1). With the exception of the serum bicarbonate levels, the
other electrolytes (potassium, sodium, and chloride) showed no comparable change. In
the normals the bicarbonate tended to rise while in the cirrhotics it fell.
B. Responses to intravenous insulin
The intravenous administration of insulin to control adult subjects produced a
distinct decrease in blood sugar, serum inorganic phosphorus, bicarbonate, and potas-
sium, and a rise in chloride and sodium. These findings are shown in Figure 2. Similar
amounts of insulin given to adult cirrhotics produced less of a decrease in blood sugar
and in serum inorganic phosphorus. The statistically significant differences are indi-
cated in the figure. The changes in the levels of potassium, bicarbonate, sodium, and
chloride were comparable in direction and in degree in the two groups.
C. Effects of glucose and insulin in combination
The blood sugar levels followed a similar pattern in the cirrhotic and in the control
subjects. Except as marked, the visible differences are not statistically significant. The
average rates of glucose disappearance between 0 to 30 and 0 to 60 minutes are vir-
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FIG. 1. Intravenous glucose tolerance test in cirrhosis. Glucose (0.5 gram per kilo-
gram of body weight in three to five minutes at zero time) produced greater hypergly-
cemia and ultimately a greater decrease in phosphorus in these 19 patients with cir-
rhosis. Statistically significant differences are indicated by asterisks. The decrease in
serum total COs content (expressed as HCOs) in the cirrhotics reflects an unidentified
disturbance in anion-cation balance. Blood sugar and serum phosphorus changes are
expressed in mgm.%; all others in mEq. per liter.
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FIG. 2. Lesser hyperglycemia and lesser hypophosphatemia following insulin admin-
istration in cirrhosis. Crystalline insulin (0.1 unit per kilogram) was administered
intravenously at zero time to 11 cirrhotics and 9 healthy adults. The response of the
cirrhotics is indicated by solid columns.
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tually identical (Table 1) and hence in keeping with the similarity of the blood sugar
curves. The phosphorus drop at 60 minutes was of lesser degree in the cirrhotics than
in the controls. The bicarbonate fell early in the cirrhotic group in contrast to the
uniformly persistent increases in the healthy adults. These changes and the statistically
significant differences in the sodium and chloride responses are shown in Figure 3.
D. Blood sugar and electrolyte levels following glucagon
In four adult cirrhotics only the rise in blood sugar and the associated decrease in
serum inorganic phosphorus appear to be of lesser magnitude than the changes
observed in healthy adults (Figs. 4a and 4b).
E. Epinephrine hyperglycemia and associated changes
From Figure 5 it is evident that in cirrhosis epinephrine produced less of a rise in
venous blood sugar, less of a decrease in serum potassium, phosphorus and bicarbonate
levels, and a decrease rather than a rise in the serum chloride.
DISCUSSION
The discussion which follows is predicated on certain assumptions based
on available information.'m It has been assumed, for example, that a carbo-
hydrate load which does not result in glycosuria can be disposed of by
deposition as liver or tissue glycogen or by anaerobic glycolysis within cells.
Also, insulin without an accompanying carbohydrate load accelerates
anaerobic glycolysis, increases muscle glycogen, and, when given in suf-
ficient amounts, depletes liver glycogen. Insulin in combination with glucose
on the other hand augments anaerobic glycolysis and replenishes both liver
and tissue glycogen. Finally, it has been assumed that glucagon and
epinephrine each result in hepatic glycogenolysis while only epinephrine
decreases muscle glycogen.
Insofar as accompanying electrolyte changes are concerned it has been
postulated that anaerobic glycolysis is accompanied by a decrease in serum
inorganic phosphorus and, demonstrable under appropriate conditions, by
a fall in serum potassium. In keeping with findings on analysis of tissue it
has been assumed that deposition of liver glycogen preempts potassium but
not inorganic phosphorus.'m The concomitants of muscle and other tissue
glycogen formation are not known. Only speculation is possible concerning
the mechanisms whereby levels of the other electrolytes are altered. Though
water shifts undoubtedly occur, as in glucose loading or removal, it cannot
be the sole factor because the changes in the individual electrolytes are not
always in the same direction. It is reasonable to suppose that variations in
serum total CO2 content reflect net anion-cation shifts, i.e., accumulation or
removal, though primary respiratory adjustments and, to a lesser extent,
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FIG. 3. Insulin and glucose tolerance tests. Glucose (as in Fig. 1) followed immedi-
ately by crystalline insulin (as in Fig. 2) produced identical responses in 9 cirrhotics
(solid columns) and in 6 controls.
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FIGS. 4a and 4b. Changes in blood sugar and serum electrolyte following glucagon.
Glucagon, 16 gamma per kilogram of body weight, was given at zero time with lesser
hyperglycemia and a smaller decrease in the serum inorganic phosphorus in the
patients with cirrhosis (solid lines).
368
.-Olp
.0- 1-- --
OOWCarbohydrate metabolism in cirrhosis DANOWSKI, GILLESPIE,
FERGUS, PUNTERERI
renal adjustments may play a role. The mechanisms of the chloride and
sodium changes, when they do occur, remain obscure but may well repre-
sent ion exchange phenomena.
A. CHANGES COMPATIBLE WITH DECREASED ABILITY OF THE CIRRHOTIC
TO LAY DOWN LIVR GLYCOGEN
There were clear-cut differences between the blood sugar responses of the
cirrhotic and the healthy adult to intravenous glucose, intravenous insulin,
intravenous glucagon, and subcutaneous epinephrine. The greater hypergly-
cemia following glucose, the lesser hypoglycemia after insulin, and the lesser
blood sugar rises in response to glucagon and epinephrine are all in keeping
with the recognized diminished ability of the cirrhotic to store liver
glycogen.
B. EVIDENCE OF GREATER ANAEROBIC GLYCOLYSIS IN CIRRHOTICS
PRESENTED WITH A GLUCOSE LOAD
The serum inorganic phosphorus changes during these intravenous
glucose tolerance tests in cirrhotics show enhanced peripheral disposal of
glucose by processes involving phosphorylation. This could be explained by
the relatively greater carbohydrate load presented to extrahepatic tissues by
virtue of decreased deposition of glucose as liver glycogen. Such an inter-
pretation is in keeping with the demonstration by Pollack and his colleagues
that the major portion and perhaps all of the loss of serum inorganic phos-
phorus following glucose administration is related to anaerobic glycolysis
in extrahepatic tissues. "'
C. EXISTENCE OF A POSSIBLE ANTI-INSULIN FACTOR OR EFFECT IN CIRRHOTICS
However, defective deposition or release of glycogen cannot explain the
diminished hypoglycemic-hypophosphatemic-hypokalemic action of insulin
in cirrhosis. It might therefore be postulated that at least the immediate
effectiveness of exogenous insulin is partially cancelled in patients with cir-
rhosis. Such inhibition of insulin action could be mediated through the
insulinase-anti-insulinase system studied by Mirsky and by others"' or it
might be related to the insulin resistance encountered in some patients with
high levels of gamma globulin.' If this be true, then similar inhibition of
endogenous insulin action could play a role in the undue hyperglycemia
noted in glucose tolerance tests and perhaps in the diminished electrolyte
changes following glucagon or epinephrine administration. In the last two,
of course, a decreased availability of liver glycogen stores must also be a
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FIG. 5. Blood sugar and electrolyte responses in normals and in cirrhotics following
epinephrine. The administration of epinephrine free of norepinephrine as indicated in
the text produced less hyperglycemia, less hypokalemia, and less hypophosphatemia in
14 cirrhotics than in 11 healthy adults. In addition, the serum chloride decreased and
the fall in serum total C02 content (HCO3) was less.
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factor. However, in view of the uncertainty whether glucagon and
epinephrine enhance, inhibit, or have no effect upon the peripheral disposal
of glucose,6'8'17 '"'8 further discussion along this line is premature.
D. CANCELLATION OF ENHANCED ANAEROBIC GLYCOLYSIS AND OF INSULIN
INHIBITION IN CIRRHOTICS GIVEN GLUCOSE AND INSULIN
IN COMBINATION
The virtually equivalent responses of the blood sugar of the healthy
control subjects and of the cirrhotic patients to intravenous glucose and
insulin in combination are compatible with three hypotheses: (i) that
under these circumstances the limited ability of the cirrhotic to store glucose
as glycogen is enhanced, (ii) that glucose is removed by deposition as extra-
hepatic tissue glycogen or, (iii) that under these circumstances anaerobic
glycolysis occurs in the cirrhotic at a rate which is increased sufficiently to
make the over-all disposal of the carbohydrate load comparable in the two.
There is no support in the serum inorganic phosphorus data for the last
hypothesis (Fig. 3). From our limited observations it would appear, there-
fore, that when glucose and insulin are given to a cirrhotic in combination
onie does not see either the enhanced anaerobic glycolysis which follows
glucose alone, nor the partial cancellation of insulin action evident after
insulin per se. It may be that under these circumstances the glucose load is
deviated to hepatic or extrahepatic glycogen.
SUMMARY AND CONCLUSIONS
1. Studies of blood sugar changes in cirrhotics given glucose, glucagon,
or epinephrine show relative hyper- or hypoglycemia compatible with
diminished ability to lay down or release liver glycogen.
2. The greater decrease in serum inorganic phosphorus following glucose
infusion to patients with cirrhosis indicates that anaerobic glycolysis is
enhanced even though the over-all glucose disappearance rate is less than in
healthy control subjects.
3. Insulin administered intravenously has less of a hypoglycemic action
in cirrhotics. This cannot be explained by diminished stores of liver glyco-
gen since this would only tend to accentuate the hypoglycemic effect. The
hypothesis is therefore advanced that in cirrhotic patients there occurs a
partial concellation of the action of exogenous insulin.
4. In the cirrhotic the combined administration of glucose and insulin
eliminates both the enhanced anaerobic glycolysis following glucose alone
and the lesser hypoglycemia observed with insulin per se. Glucose disposal
rates are of the same order of magnitude as in the healthy adult.
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